BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swick TJ. Treatment paradigms for cataplexy in narcolepsy: past, present, and future. Nat Sci Sleep 2015;7:159-69. [PMID: 26715865 DOI: 10.2147/NSS.S92140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Meinen CN, Smith KM, Tillema JM, Kotagal S. Pseudo Status Cataplecticus in Narcolepsy Type 1. J Clin Sleep Med 2018;14:1625-7. [PMID: 30176979 DOI: 10.5664/jcsm.7350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Med Rev 2019;43:23-36. [PMID: 30503715 DOI: 10.1016/j.smrv.2018.09.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
3 Tzeng NS, Hsing SC, Chung CH, Chang HA, Kao YC, Mao WC, Yang CCH, Kuo TBJ, Chen TY, Chien WC. The Risk of Hospitalization for Motor Vehicle Accident Injury in Narcolepsy and the Benefits of Stimulant Use: A Nationwide Cohort Study in Taiwan. J Clin Sleep Med 2019;15:881-9. [PMID: 31138389 DOI: 10.5664/jcsm.7842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep 2017;9:39-57. [PMID: 28424564 DOI: 10.2147/NSS.S103467] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 9.4] [Reference Citation Analysis]
5 Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications. CNS Drugs 2022. [PMID: 35635687 DOI: 10.1007/s40263-022-00926-0] [Reference Citation Analysis]
6 Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns. Nat Sci Sleep 2020;12:453-66. [PMID: 32765142 DOI: 10.2147/NSS.S162762] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wenthur CJ. Classics in Chemical Neuroscience: Methylphenidate. ACS Chem Neurosci 2016;7:1030-40. [PMID: 27409720 DOI: 10.1021/acschemneuro.6b00199] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
8 Calik MW. Update on the treatment of narcolepsy: clinical efficacy of pitolisant. Nat Sci Sleep 2017;9:127-33. [PMID: 28490912 DOI: 10.2147/NSS.S103462] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 6.2] [Reference Citation Analysis]
9 Vanek J, Prasko J, Ociskova M, Genzor S, Holubova M, Hodny F, Nesnidal V, Slepecky M, Sova M, Minarikova K. Sleep Disturbances in Patients with Nonepileptic Seizures. Nat Sci Sleep 2021;13:209-18. [PMID: 33623462 DOI: 10.2147/NSS.S289190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bajestan SN, LaFrance WC Jr. Clinical Approaches to Psychogenic Nonepileptic Seizures. Focus (Am Psychiatr Publ) 2016;14:422-31. [PMID: 31975822 DOI: 10.1176/appi.focus.20160020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]